Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
IMMUCELL CORP (ICCC)
|
Add to portfolio |
|
|
|
| Price: |
$9.05
| | Metrics |
| OS: |
7.75
|
M
| |
|
|
| Market cap: |
$70.1
|
M
| |
|
|
|
Net debt:
|
$10.7
|
M
| |
|
|
|
EV:
|
$80.8
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 19.2 | 15.3 | 13.7 | 11.0 | 10.4 | 9.5 | 10.8 | 8.0 |
| Revenue growth | 25.4% | 11.8% | 24.9% | 5.3% | 9.3% | -11.6% | 34.6% | 25.3% |
| Cost of goods sold | 10.6 | 8.5 | 7.0 | 5.8 | 5.2 | 4.1 | 4.0 | 3.1 |
| Gross profit | 8.7 | 6.9 | 6.7 | 5.2 | 5.2 | 5.4 | 6.8 | 4.9 |
| Gross margin | 45.0% | 44.7% | 49.1% | 47.3% | 50.1% | 56.8% | 63.2% | 60.8% |
| Selling, general and administrative | | | | | | | | |
| Sales and marketing | 2.5 | 2.2 | 2.3 | 2.1 | 1.9 | 1.8 | 1.6 | 1.3 |
| Research and development | 4.2 | 4.4 | 3.7 | 3.5 | 2.0 | 1.2 | 1.2 | 2.2 |
| General and administrative | 1.7 | 1.7 | 1.7 | 1.7 | 1.5 | 1.5 | 1.3 | 1.2 |
| EBITA | 0.3 | -1.4 | -0.9 | -1.4 | -0.2 | 0.9 | 2.1 | -0.2 |
| EBITA margin | 1.4% | -8.9% | -6.8% | -13.0% | -2.1% | 9.5% | 19.6% | -2.5% |
| Amortization of intangibles | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 0.0 |
| EBIT | 0.3 | -1.4 | -1.0 | -1.4 | -0.2 | 0.9 | 2.1 | -0.2 |
| EBIT margin | 1.3% | -9.0% | -7.0% | -13.2% | -2.3% | 9.3% | 19.6% | -2.6% |
| Pre-tax income | -0.1 | -1.0 | -1.3 | -1.9 | -0.4 | 0.8 | 2.1 | -0.3 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.5 | -0.3 | 0.2 | 0.9 | -0.1 |
| Tax rate | | 1.0% | | | 61.7% | 33.0% | 41.2% | 34.6% |
| Net income | -0.1 | -1.0 | -1.3 | -2.3 | -0.2 | 0.5 | 1.2 | -0.2 |
| Net margin | -0.4% | -6.7% | -9.4% | -21.1% | -1.6% | 5.3% | 11.2% | -2.1% |
| |
| Diluted EPS | ($0.01) | ($0.14) | ($0.19) | ($0.42) | ($0.03) | $0.12 | $0.38 | ($0.06) |
| Shares outstanding (diluted) | 7.6 | 7.2 | 6.8 | 5.5 | 4.9 | 4.3 | 3.2 | 3.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|